1.83 USD
↗ 0.04 (2.24%)AT CLOSE (11:59 AM EDT)
Aldeyra Therapeutics, Inc.
ALDXNASDAQ • USD
1.80
↘ 0.03 (1.64%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
1.80
↘ 0.03 (1.64%)
Market: CLOSED
Open?$1.80
High?$1.87
Low?$1.77
Prev. Close?$1.79
Volume?1.8M
Avg. Volume?5.4M
VWAP?$1.82
Rel. Volume?0.34x
Bid / Ask
Bid?$1.77 × 3.1K
Ask?$1.82 × 100
Spread?$0.05
Midpoint?$1.80
Valuation & Ratios
Market Cap?110.1M
Shares Out?60.2M
Float?49.5M
Float %?82.2%
P/E Ratio?N/A
P/B Ratio?2.49
EPS?-$0.56
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?2.58Strong
Quick Ratio?2.58Strong
Cash Ratio?2.52Strong
Debt/Equity?0.34Low
ValuationATTRACTIVELY VALUED
Score100/100
P/E?N/A▾
P/B?2.49CHEAP▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.6CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?-76.5%WEAK▾
ROA?-47.0%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$55.3M
Related Companies
Loading...
News
Profile
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
Address
131 HARTWELL AVENUE
LEXINGTON, MA 02421
Phone: 781-761-4904
LEXINGTON, MA 02421
Phone: 781-761-4904